|Year : 2018 | Volume
| Issue : 4 | Page : 166
Medical news – from around the World
|Date of Web Publication||16-Apr-2019|
Source of Support: None, Conflict of Interest: None
|How to cite this article:|
. Medical news – from around the World. Curr Med Issues 2018;16:166
| New Registration System for Pharmacists in India|| |
The Pharmacy Council of India (PCI) has launched a national digital platform for registration and tracking of pharmacists titled “Pharmacist Registration and Tracking System.” Accordingly, all the registered pharmacists in the country are requested to fill their pharmacist registration details by registering and logging into the user management system provided in the official website of PCI. The system has been launched early this month in New Delhi for pharmacists registered with Delhi State Pharmacy Council. The same will be rolled out throughout the country by December 1, 2018. PCI believes that this system will provide information on demographics of pharmacists in the country, their employment status, and their area of work (e.g., hospital, educational institutions, community pharmacy, or pharmaceutical industry). The system requires only registered pharmacists (with respective state pharmacy councils) to update their data. Based on the information collected by the system, the council is set to draft policies to address challenges faced by the pharmacy profession. The system may also help address certain malpractices in the profession as it will ensure registration of only qualified pharmacists. It will also prevent pharmacists from unauthorized renting of the registration certificate. A pharmacist needs to upload information onto the system whenever he/she gets employed by company/institution or switches the employment. The system also applies for pharmacists registered within India and work abroad.
Source:PCI Launches Pharmacist Registration and Tracking System to Capture Pharmacist Data Pan India[Internet].[cited 2018 Nov 22]<http://www.pharmabiz.com/NewsDetails.aspx?aid=112343&sid=1>.
| Google Bans Apps Promoting Unapproved Pharmaceuticals|| |
Google has made an announcement that it will be purging all apps that promote or sell unapproved pharmaceutical substances or provide free health tips and ways to remain fit by promoting illegal substances from the Google Play Store.
Google specified that apps selling products containing ephedrine, or those containing human chorionic gonadotropin for weight loss or weight control, or when promoted in conjunction with anabolic steroids, will get banned. Furthermore, apps promoting herbal and dietary supplements with active pharmaceutical or dangerous ingredients will find no place in the Google Play Store.
Apps containing contents related to alternative medicine or medical procedure that is not approved by the government will also be removed from the play store.
Source: Google Bans Apps that Promote false Health Tips or Banned Medical Substances – Times of India. The Times of India[Internet]. The Times of India. [cited 2019 Jan 25].
| Aortic dissections with fluoroquinoloneantibiotics|| |
A recent FDA review found that fluoroquinolone antibiotics can increase the occurrence of rare but serious events of ruptures or dissections in the aorta. These aortic dissection or rupture can occur with fluoroquinolones for systemic use given by mouth or injection.
The FDA recommends healthcare professionals to avoid prescribing fluoroquinolone antibiotics or prescribe only when no other treatment options are available to patients who have an aortic aneurysm or are at increased risk for an aortic aneurysm, such as patients with peripheral atherosclerotic vascular diseases, hypertension, certain genetic conditions such as Marfan Syndrome and Ehlers-Danlos syndrome More Details, and elderly patients.
Source: Safety Alerts for Human Medical Products -Fluoroquinolone Antibiotics: Safety Communication -Increased Risk of Ruptures or Tears in the Aorta Blood Vessel in Certain Patients [Internet]. [cited 2019 Jan 14].